FDA approves first cell-based gene therapy for adult patients with multiple myeloma
For immediate release: March 27, 2021 The Food and Drug Administration has approved Abecma (idecabtagene vicleucel), a cell-based gene therapy to treat adult patients with multiple myeloma who have…
